ArticleClinical drug investigation2024

Comparison of Long-Term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis Between Dupilumab-Exposed and Dupilumab-Naïve Patients.

Maddalena Napolitano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.